Q3 2021 Seres Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Seres Therapeutics Third Quarter Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Dr. Carlo Tanzi, Investor Relations. Please go ahead.
Thank you, and good morning. Our press release with the company's third quarter 2021 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors & News section of the company's website. I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, the anticipated safety profile of our products regulatory approval, the success of our agreement with health science, the anticipated market for SER-109 and the promise and potential impact of any of our microbiome therapeutics.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |